Inventor
ERICA SHANE
Inventor
US
Overview
Patents· 4 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes33%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations33%
C12NMicroorganisms or enzymes25%
C07KPeptides8%
PatentTitleYear
12,257,297Vaccine compositions having improved stability and immunogenicity202511,364,294Vaccine compositions having improved stability and immunogenicity202211,253,585Vaccine compositions having improved stability and immunogenicity202211,180,542Stabilized liquid anti-RSV antibody formulations2021Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2021Patents assigned to AREXIS AB (1)· patent assignee history
2021–2025Based in US· patent location history
2022–2025Patents assigned to NOVAVAX INC (3)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| NOVAVAX INC | 3 | 2022–2025 |
| AREXIS AB | 1 | 2021 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 4 | 2021–2025 |